AWS Announces General Availability of Amazon EBS io2 Block Express Volumes
io2 volumes running on next-generation Block Express architecture deliver the first storage area network (SAN) built for the cloud to...
Day: July 19, 2021
deCODE genetics – New study on inheritance and fetal growth
REYKJAVIK, Iceland, July 19, 2021 /PRNewswire/ -- In a paper published in Nature genetics today, Scientists from deCODE genetics, a...
Aquarius Surgical Technologies Announces Anticipated Delay in Filing of Annual Financial Results for the Year Ended March 31, 2021
TORONTO, ON / ACCESSWIRE / July 19, 2021 / Aquarius Surgical Technologies Inc. (Ticker symbol - CSE:ASTI) ("ASTI" or the...
Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC
FORT WORTH, TX / ACCESSWIRE / July 19, 2021 / Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech...
Jupiter Wellness Announces Multi-Year Distribution Agreement with Rigour International for Expansion in Asia
JUPITER, FL / ACCESSWIRE / July 19, 2021 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today announced a multi-year agreement with Rigour...
9 Meters Biopharma, Inc. Announces the Acquisition of Humanized Anti-GIP Monoclonal Antibody from Lobesity
- Broadens existing pipeline with a monoclonal antibody against a novel target, glucose-dependent insulinotropic polypeptide (GIP) -- First planned indication...
Novus Signs Partnership With PRAM, a Leading Pharmacy Consulting, and Underwriting Firm
Proud to be Aligned with a Proprietary Prescription Drug Benefits Powerhouse As We Begin Our Roll Out To Their Distribution...
Napo EU S.p.A., Jaguar Health’s Italian Subsidiary, and Dragon SPAC S.p.A. Announce Close of 8,830,000 Euro Dragon SPAC Financing
Napo EU, the identified target of Dragon SPAC, seeks to develop plant-based crofelemer to potentially treat orphan disease - short...
NLS Pharmaceutics Announces the Appointment of Eric Konofal, M.D., Ph.D. as Chief Scientific Officer
STANS, SWITZERLAND / ACCESSWIRE / July 19, 2021 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW), a Swiss clinical-stage pharmaceutical company focused on...
EPI Health and MC2 Therapeutics announces U.S. Launch of Wynzora® Cream for Plaque Psoriasis (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%)
Now available: Wynzora® Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%) once-daily topical treatment of plaque psoriasis in adults 18 years...
Kadmon Announces Pivotal Trial Data Published in the Journal Blood for REZUROCK(TM) (Belumosudil) in Chronic Graft-Versus-Host Disease (cGVHD)
- REZUROCK is approved by the U.S. FDA for the treatment of adult and pediatric patients 12 years and older...
Todos Medical to Launch EUA Authorized cPass SARS-CoV-2 Neutralizing Antibody Kit Through Agreement with Fosun Pharma
Nature Medicine publication shows that neutralizing antibodies are critical to prevent or reduce the severity of a COVID-19 infection, including...
Fountain Therapeutics to Present at 2nd Annual LifeSci Partners Private Company Summer Symposium
SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Fountain Therapeutics, a biopharmaceutical company building a pipeline of therapeutics...
INmune Bio, Inc. Announces Poster Presentation and Plenary Talk at the Alzheimer’s Association International Conference 2021
Company to introduce design of upcoming Phase 2 study of XPro1595 in Alzheimer’s disease, which is expected to commence this...
Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer
Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company’s Phenoptics™ multiplex...
Catalyst Pharmaceuticals Announces Issuance of U.S. Patent 11,060,128 a Method of Use Patent with Claims Covering Firdapse®
New patent bolsters intellectual property protection for Firdapse®First in a family of four pending patents for Firdapse® to issueCORAL GABLES,...
Albireo Receives European Marketing Authorization of Bylvay™ (odevixibat), the First Drug Treatment for Progressive Familial Intrahepatic Cholestasis (PFIC)
– First approval in the world of Bylvay for the treatment of PFIC – – Only once-daily drug indicated to...
Frontier Medicines Raises $88.5 Million Series B Financing to Advance Precision Oncology and Targeted Protein Degradation Pipeline
—Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further...
BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Deal strengthens BioNTech’s cell therapy pipeline by accelerating individualized solid tumor Neoantigen TCR cell therapy research and development program and...
Celsion Reports Data Safety Monitoring Board Recommendation to Continue Dosing Patients in the Phase II Portion of the OVATION 2 Study with GEN-1 in Advanced Ovarian Cancer
OVATION 2 Study is 50% Enrolled; Excellent R0 Surgical Resection Noted Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable...